{"id":2078,"date":"2024-04-17T13:20:36","date_gmt":"2024-04-17T13:20:36","guid":{"rendered":"https:\/\/stoxpo.com\/?p=2078"},"modified":"2024-04-17T13:20:37","modified_gmt":"2024-04-17T13:20:37","slug":"vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/","title":{"rendered":"Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\">Board Determines Offers Undervalue Company&#8217;s Robust Growth Prospects<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Vanda Pharmaceuticals (VNDA) has confirmed receiving multiple unsolicited acquisition proposals from Future Pak, LLC (&#8220;Future Pak&#8221;) since March 2024. The most recent proposal, dated April 1, offered $7.25 &#8211; $7.75 per share, subject to certain conditions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">After careful review by the Vanda Board of Directors (the &#8220;Board&#8221;), along with independent financial and legal advisors, the Board unanimously concluded that the offers are not in the best interests of the Company and its shareholders. The Board believes the proposals significantly undervalue Vanda, considering its robust clinical development pipeline, expanding commercial presence, significant cash balance, and long-term growth prospects.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Despite Future Pak&#8217;s attempts, the Board maintains confidence in Vanda&#8217;s resilient business model, diverse product portfolio, history of top-line growth, and durable cash flow. The Conditional Proposals are deemed opportunistic and would transfer significant value from shareholders to Future Pak at the expense of Vanda&#8217;s intrinsic value.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With Future Pak&#8217;s latest proposal offering only a modest premium to Vanda&#8217;s cash balance, shareholders are advised to take no action at this time.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read original press release:<a href=\"https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-confirms-rejection-of-unsolicited-takeover-proposals-from-future-pak-302119534.html\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">here<\/mark><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/silver-market-deficit-expected-to-grow-in-2024\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Silver Market Deficit Expected to Grow in 2024<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Board Determines Offers Undervalue Company&#8217;s Robust Growth Prospects Vanda Pharmaceuticals (VNDA) has confirmed receiving multiple unsolicited acquisition proposals from Future Pak, LLC (&#8220;Future Pak&#8221;) since March 2024. The most recent proposal, dated April 1, offered $7.25 &#8211; $7.75 per share, subject to certain conditions. After careful review by the Vanda Board of Directors (the &#8220;Board&#8221;), [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1429,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"1","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[360,309],"tags":[],"coauthors":[453],"class_list":["post-2078","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mid-cap","category-pharmaceuticals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Board Determines Offers Undervalue Company&#8217;s Robust Growth Prospects Vanda Pharmaceuticals (VNDA) has confirmed receiving multiple unsolicited acquisition proposals from Future Pak, LLC (&#8220;Future Pak&#8221;) since March 2024. The most recent proposal, dated April 1, offered $7.25 &#8211; $7.75 per share, subject to certain conditions. After careful review by the Vanda Board of Directors (the &#8220;Board&#8221;), [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-17T13:20:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-17T13:20:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-chokniti-khongchum-2280571-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1709\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liliana Vida\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liliana Vida\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/\"},\"author\":{\"name\":\"Liliana Vida\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\"},\"headline\":\"Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak\",\"datePublished\":\"2024-04-17T13:20:36+00:00\",\"dateModified\":\"2024-04-17T13:20:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/\"},\"wordCount\":204,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-chokniti-khongchum-2280571-scaled.jpg\",\"articleSection\":[\"Mid-Cap\",\"Pharmaceuticals\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/\",\"name\":\"Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-chokniti-khongchum-2280571-scaled.jpg\",\"datePublished\":\"2024-04-17T13:20:36+00:00\",\"dateModified\":\"2024-04-17T13:20:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-chokniti-khongchum-2280571-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-chokniti-khongchum-2280571-scaled.jpg\",\"width\":2560,\"height\":1709,\"caption\":\"chemistry-2\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/04\\\/17\\\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\",\"name\":\"Liliana Vida\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"caption\":\"Liliana Vida\"},\"description\":\"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/stoxpo-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/","og_locale":"en_US","og_type":"article","og_title":"Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak - Stoxpo","og_description":"Board Determines Offers Undervalue Company&#8217;s Robust Growth Prospects Vanda Pharmaceuticals (VNDA) has confirmed receiving multiple unsolicited acquisition proposals from Future Pak, LLC (&#8220;Future Pak&#8221;) since March 2024. The most recent proposal, dated April 1, offered $7.25 &#8211; $7.75 per share, subject to certain conditions. After careful review by the Vanda Board of Directors (the &#8220;Board&#8221;), [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/","og_site_name":"Stoxpo","article_published_time":"2024-04-17T13:20:36+00:00","article_modified_time":"2024-04-17T13:20:37+00:00","og_image":[{"width":2560,"height":1709,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-chokniti-khongchum-2280571-scaled.jpg","type":"image\/jpeg"}],"author":"Liliana Vida","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liliana Vida","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/"},"author":{"name":"Liliana Vida","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1"},"headline":"Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak","datePublished":"2024-04-17T13:20:36+00:00","dateModified":"2024-04-17T13:20:37+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/"},"wordCount":204,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-chokniti-khongchum-2280571-scaled.jpg","articleSection":["Mid-Cap","Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/","url":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/","name":"Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-chokniti-khongchum-2280571-scaled.jpg","datePublished":"2024-04-17T13:20:36+00:00","dateModified":"2024-04-17T13:20:37+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-chokniti-khongchum-2280571-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-chokniti-khongchum-2280571-scaled.jpg","width":2560,"height":1709,"caption":"chemistry-2"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2024\/04\/17\/vanda-pharmaceuticals-rejects-unsolicited-acquisition-proposals-from-future-pak\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1","name":"Liliana Vida","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6","url":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","caption":"Liliana Vida"},"description":"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/stoxpo-com\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=2078"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2078\/revisions"}],"predecessor-version":[{"id":2079,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/2078\/revisions\/2079"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1429"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=2078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=2078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=2078"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=2078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}